Wenqi Li

1.2k citations
53 papers · 694 indexed · h-index 15

Wenqi Li

51 papers receiving 682 citations

Peers

Wenqi Li
Comparison fields: 5 of 101
  • Cancer Research 64
  • Nephrology 30
  • Biochemistry 25
  • Molecular Biology 280
  • Immunology 85
Replace Ruolan Dong with:
Ruolan Dong China
Xuemei Gu China
Xuexue Zhu China
Abdel‐Aziz H. Abdel‐Aziz Egypt
Chia-Yao Shen Taiwan
Naureen Fatima India
Ali A. Abo‐Saif Egypt
Shuang Xia China
Ting Jiang China
Wenqi Li relative to Ruolan Dong China Ruolan Dong's profile →
Citations per field
00.5×1.5×2.5×
Ruolan Dong · 1×
Citations per year

Countries citing papers authored by Wenqi Li

Since Specialization
Citations

This map shows the geographic impact of Wenqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqi Li more than expected).

Fields of papers citing papers by Wenqi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqi Li. The network helps show where Wenqi Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wenqi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenqi Li Line = papers co-authored together Wenqi Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20254
3 20242
4 20240
5 20244
6 20243
7 20241
8 20232
9 20236
10 202320
11 202214
12 202051
13 202010
14 202075
15 202016
16 20194
17 201938
18 201629
19
[Application study on regional infusion chemotherapy by celiac trunk during operation in advanced gastric cancer patients].
20161
20
[Electrophysiological findings and ablation strategies in patients with atrial tachyarrhythmias after left atrial circumferential ablation in the treatment of atrial fibrillation].
20071

About Wenqi Li

Wenqi Li is a scholar working on Immunology, Oncology and Applied Microbiology and Biotechnology, having authored 53 papers that have together received 694 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Cardiac Arrhythmias and Treatments (5 papers), Cardiac pacing and defibrillation studies (3 papers), Sperm and Testicular Function (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Cancer Research (64 citations), Nephrology (30 citations) and Biochemistry (25 citations). Wenqi Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lulu Zang, Jinmeng Zhao, Jinjin Yu, Xiaofeng Niu, Weifeng Li, Meiping Guan, Dan Wang, Zongji Zheng, Xin Xiao and Yaoming Xue. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026